查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854610

急性腦室引流市場按應用、最終用戶、產品類型、技術、引流類型、病患年齡層和通路分類－2025-2032年全球預測

Acute External Ventricular Drain Market by Application, End User, Product Type, Technology, Drainage Type, Patient Age Group, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，急性腦室引流市場規模將達到 5.8444 億美元，複合年成長率為 10.30%。

主要市場統計數據
基準年 2024 2.6664億美元
預計年份：2025年 2.9393億美元
預測年份：2032年 5.8444億美元
複合年成長率 (%) 10.30%

簡要說明了影響現代重症加護。

急性期腦室內引流（EVD）系統仍然是重症加護的基石，在腦脊髓液分流、顱內壓監測和急診神經外科手術中發揮著至關重要的作用。現代臨床實務強調對水腦症、蜘蛛網膜下腔出血、創傷性腦損傷和複雜性顱內高壓患者進行快速、規範的主導。因此，臨床醫生和醫療系統必須在臨床療效、感染預防、易用性和工作流程效率之間取得平衡。這些優先事項影響了急性護理機構的採購考量和採購管道。

技術發展和醫療管道的轉變正在改變人們對伊波拉病毒疾病（EVD）設備的期望，使其從一次性預包裝套件轉向更模組化、可重複使用且設計用於永續營運模式的系統。同時，監管機構對設備無菌性、上市後監測和臨床結果的審查日益嚴格，促使製造商加強基於實證醫學的包裝設計。總而言之，這些動態共同作用，使得臨床需求、醫院營運限制和監管要求影響設備的設計、分銷和應用。

感染控制優先事項、分散式醫療管道以及以整體擁有成本為中心的採購方式如何再形成醫療器材設計和商業化策略

過去幾年，醫院和專科中心在急性期腦室外引流管的設計、供應和使用方面發生了顯著變化。臨床上對最大限度減少感染和提高監測準確性的重視，促使人們採用封閉式系統技術和整合壓力感測器。同時，醫療服務模式正在將一些神經外科手術分散到門診手術中心和專科診所，這改變了需求模式並影響了庫存策略。

此外，採購團隊越來越關注整體擁有成本，傾向於選擇可減少再處理負擔的一次性套裝，同時也在探索可透過完善的滅菌通訊協定進行最佳化的可重複使用系統。數位健康整合和遠端監測正開始出現在相關設備生態系統中，而可追溯性和不利事件報告的法律規範也在不斷完善，這促使製造商優先考慮上市後資料收集。這些轉變的匯聚迫使現有供應商和新參與企業重新思考其產品藍圖和商業策略，以符合臨床醫生的偏好和機構的要求。

美國關稅結構調整對商業和供應鏈的影響，以及對製造商和醫療保健系統在2025年需要做出的策略選擇的預測

美國關稅政策預計將於2025年發生變化，這將對醫療設備（包括急性護理腦室外引流組件和組裝）的採購和供應鏈產生重要影響。關稅調整將影響進口原料和成品的到岸成本，進而可能影響籌資策略、供應商談判以及國內外工廠之間的產能分配。因此，採購團隊和製造商必須評估供應商合約、對沖策略以及可能轉嫁給最終用戶的成本，同時也要考慮醫院的預算限制。

為應對這一局面，製造商可能會加強實現本地化生產，篩選合格的替代供應商，並重新設計產品組件，以減少對受關稅影響的零件的依賴。醫院和集團採購組織可能會更嚴格地審查合約條款和庫存管理，並要求提高成本促進因素的透明度。值得注意的是，關稅相關的成本壓力可能會加速人們對簡化物流的一次性組件的需求，或者相反，也可能促使人們重新關注可重複使用的系統，這些系統可以透過資本投資和本地消毒來降低對進口產品的風險。應對這種環境需要商業、監管和供應鏈團隊通力合作，制定應對方案，以在保障臨床可用性的同時保護淨利率。

一項綜合評估揭示了臨床適應症、醫療保健環境、產品架構和分銷管道如何影響設備設計和銷售管道。

細分市場分析揭示了不同臨床應用、終端使用者、產品類型、技術、引流方法、患者族群特徵和分銷模式的促進因素和採用管道存在差異。在應用領域內，設備設計和臨床工作流程直接滿足水腦症管理、顱內壓監測、蜘蛛網膜下腔出血治療和創傷性腦損傷管理的需求，每種適應症對監測精度、導管耐用性和感染控制都有獨特的要求。對於終端使用者而言，門診手術中心、醫院和專科診所的手術量、無菌處理能力和採購權限各不相同，這影響了組裝一次性套件和集中再處理系統的吸引力。

依產品類型分類，突顯了一次性套裝和可重複使用系統之間的差異。一次性套裝有高配置和標準配置兩種選擇，當一次性無菌操作和簡化的手術流程能夠降低感染風險和減少醫護人員時間時，它們更具吸引力；而可重複使用系統有多組件和單組件兩種形式，當滅菌基礎設施和處理能力允許成本攤銷時，它們則更受歡迎。封閉式系統通常能夠降低污染風險，並符合加護治療室等臨床醫生的偏好，而開放式系統在便利性和成本至關重要的情況下仍然適用。將患者年齡分為成人和兒童群體，也會導致導管尺寸、監測閾值和看護者培訓等方面的設計差異。最後，分銷管道包括分銷商、電商平台和醫院供應商。分銷商包括醫療設備和藥品分銷商，電商平台則透過製造商網站和第三方平台營運，而醫院供應商則透過與醫院或集團採購組織簽訂直接合約進行營運。每個分銷管道都需要量身定做的商業性合作策略、合約結構和物流計劃，以使產品供應與臨床需求相匹配。

區域動態和醫療保健系統差異將決定全球重症加護市場的採用軌跡、監管要求和商業策略。

區域動態正在影響美洲、歐洲、中東和非洲以及亞太地區的醫療設備採用模式、監管預期和競爭強度，每個地區都呈現出獨特的機會和挑戰。在美洲，先進的重症加護能力、集中的三級神經病學中心以及整合的醫院採購框架有利於採用功能豐富的封閉式系統和先進的一次性耗材包，而私人和公共支付方的動態則影響著採購時機和合約結構。過渡期照護模式和對打包支付的重視正促使醫療系統優先選擇那些能夠降低感染率和縮短住院時間的設備。

在歐洲、中東和非洲，監管協調工作和國家報銷政策正在影響市場准入和產品應用。同時，中東和非洲部分地區基礎設施的不平衡導致市場對經濟實惠的可重複使用系統和易於取得的一次性手術包的需求不斷成長。在亞太地區，神經外科手術能力的快速提升、強大的區域製造生態系統以及不斷完善的監管管道，為全球供應商和本地製造商都創造了機會。部分市場的價格敏感性，加上都市區三級醫療中心對先進解決方案日益成長的需求，迫使製造商提供差異化的產品系列和靈活的商業模式，以滿足當地需求。

競爭格局表明，規模、臨床證據和服務整合將決定供應商的差異化和市場定位。

急性腦室外引流器材領域的競爭格局由成熟的醫療技術公司、神經外科器械專家和靈活的利基創新者組成。大型製造商利用其規模、全球分銷網路和廣泛的臨床產品組合來贏得醫院契約，並提供包括培訓、上市後監測和服務協議在內的複雜提案主張。另一方面，規模較小的專業公司則致力於導管設計、封閉式系統技術和整合監測功能的創新，並經常與臨床中心合作，以檢驗產品性能並加快臨床醫生的接受度。

目的地設備製造商 (OEM) 與契約製造)之間更深入的合作，能夠加快產品迭代速度並最佳化成本，同時分散供應鏈風險。如今，策略差異化不僅取決於價格，還取決於臨床證據的產生、感染控制能力以及全生命週期服務。此外，通路策略也各不相同，有些供應商強調與醫院直接簽訂合約或參與集團採購組織，而有些供應商則利用經銷商網路和數位化管道來擴大覆蓋範圍。競爭優勢取決於臨床聲明與營運價值的契合度，以及在病患療效和工作流程效率方面取得的可衡量改善。

製造商和醫療系統可採取的策略重點，以提升神經重症重症加護領域的臨床療效、供應鏈韌性和差異化商業性執行力。

產業領導者應優先考慮在簡化供應鏈和商業執行流程的同時，保障臨床療效。首先，應投資臨床研究和真實世界證據項目，量化感染率、ICU住院時間和器械相關併發症的降低情況，並支持採購談判和報銷協調。其次，應最佳化產品系列，涵蓋一次性高級套件和可重複使用系統，使醫療機構能夠選擇符合其滅菌能力和成本控制目標的解決方案。在產品最佳化的同時，應透過雙重採購、關鍵零件近岸外包以及針對關稅主導的成本變化製定明確的應急計劃，來增強供應鏈的韌性。

在商業性，我們為門診手術中心、醫院和專科診所提供靈活的合約條款、培訓方案和循證價值命題，並根據最終用戶和地區客製化合約模式。我們積極採用數位化管道和直接面向製造商的電子商務模式，以支援快速補貨並滿足分散式臨床機構的需求。最後，我們與臨床領導者合作，共同製定簡化設備設置和維護的通訊協定，從而減少結果差異，並提升高階設備屬性的感知價值。

採用嚴謹的混合方法，結合臨床醫生的見解、監管審查和情境建模，對設備、臨床和供應鏈動態進行全面且經過驗證的檢驗。

本執行摘要的調查方法融合了定性和定量方法，以確保強力的依證和平衡的解釋。主要資料來源包括對臨床負責人、採購專業人員和工程團隊的結構化訪談，並輔以典型醫療機構流程的觀察分析。次要資料來源則利用同儕審查的臨床文獻、監管文件、設備標籤和製造商產品規格，以證實技術能力和安全性。

所採用的分析技術包括：跨產品類型的特徵比較映射、基於情境的供應鏈建模（用於評估關稅的影響）以及細分分析（用於按應用、最終用戶和分銷管道識別不同的需求叢集）。在條件允許的情況下，研究結果透過臨床專家小組和技術審查進行交叉檢驗，以確保其實際應用價值。研究還指出了局限性和數據缺口，並建議進行後續研究，以進一步了解長期臨床結果和設備生命週期經濟性。

整合臨床、營運和商業性的必要因素，以確定哪些策略方法能夠帶來持續的推廣應用，並在患者照護取得可衡量的改進。

總之，急性期腦室外引流系統在臨床需求、營運要求和商業複雜性之間起著至關重要的作用。儘管臨床上對感染控制和監測精準性的重視使得許多醫療機構傾向於使用封閉式系統和精心配置的拋棄式套件，但當消毒基礎設施能夠支持經濟高效的重複使用時，可重複使用系統就顯得尤為重要。關稅變化和區域採購動態要求積極主動的供應鏈和商業規劃，以確保供應並維持利潤結構。

能夠將強力的臨床證據與靈活的產品系列、穩健的籌資策略以及有針對性的區域性商業性模式相結合的製造商，將更有能力滿足不斷變化的臨床醫生和採購人員的期望。相較之下，醫療系統和採購團隊將受益於更清晰的整體擁有成本分析、更嚴格的通訊協定協調以及對那些能夠顯著減少併發症和工作流程負擔的醫療器材的選擇性應用。臨床相關人員、製造商和供應鏈合作夥伴之間的持續協作對於將創新轉化為患者照護可衡量的改進至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 抗菌塗層導管的廣泛應用可減少EVD相關感染疾病和併發症。
  • 來自無線顱內壓監測和腦室外引流系統整合的即時神經重症加護治療數據
  • 為最大限度降低交叉感染風險，對一次性腦室引流管的需求不斷成長
  • 開發微創導管插入技術以縮短重症重症患者的ICU住院時間
  • 擴展支援遠端醫療的伊波拉病毒病管理平台，用於遠端監測和諮詢
  • 增加對配備壓力感測器和自動引流控制演算法的智慧型腦室外引流系統的投資
  • 新型銀塗層引流管獲監管部門核准用於神經外科手術中對抗多重抗藥性病原體
  • 設備製造商和人工智慧開發商合作，最佳化加護治療中的腦室外引流裝置放置和血流通訊協定。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按應用分類的急性腦室引流市場

  • 水腦症的治療
  • 顱內壓監測
  • 蜘蛛網膜下腔出血的治療
  • 創傷性腦損傷的治療

9. 按最終用戶分類的急性腦室引流市場

  • 門診手術中心
  • 醫院
  • 專科診所

第10章 按產品類型分類的急性腦室引流市場

  • 免洗工具包
    • 高級套件
    • 標準套件
  • 可重複使用系統
    • 多組件系統
    • 單組件系統

第11章 按技術分類的急性腦室引流市場

  • 封閉系統
  • 開放系統

第12章 按引流類型分類的急性腦室引流市場

  • 連續排水
  • 間歇性排水

第13章 按病患年齡層別分類的急性腦室引流市場

  • 成人
  • 孩子們

第14章 急性腦室引流市場（依通路分類）

  • 經銷商
    • 醫療設備經銷商
    • 藥品經銷商
  • 電子商務
    • 製造商網站
    • 第三方網站
  • 醫院供應商
    • 與醫院直接簽訂合約
    • 集團採購組織

第15章 各地區急性腦室引流市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 急性腦室引流市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國急性腦室引流市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Medtronic plc
    • B. Braun Melsungen AG
    • Integra LifeSciences Corporation
    • Smiths Medical, Inc.
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • Stryker Corporation
    • ICU Medical, Inc.
    • Baxter International Inc.
    • Boston Scientific Corporation
Product Code: MRR-957C47F8FEC9

The Acute External Ventricular Drain Market is projected to grow by USD 584.44 million at a CAGR of 10.30% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 266.64 million
Estimated Year [2025] USD 293.93 million
Forecast Year [2032] USD 584.44 million
CAGR (%) 10.30%

A concise orientation to the evolving clinical, regulatory, and operational context shaping acute external ventricular drain use across modern neurocritical care settings

Acute external ventricular drain (EVD) systems remain a cornerstone of neurocritical care, playing a critical role in cerebrospinal fluid diversion, intracranial pressure monitoring, and emergency neurosurgery. Recent clinical practice has emphasized rapid, protocol-driven interventions for patients with hydrocephalus, subarachnoid hemorrhage, traumatic brain injury, and complex intracranial hypertension. Consequently, clinicians and healthcare systems are balancing the need for clinical efficacy with infection prevention, ease of use, and workflow efficiency. These priorities have shaped purchasing considerations and procurement pathways across acute care settings.

Technology developments and changing care pathways have begun to alter expectations of EVD devices, from single-use, prepackaged kits to more modular reusable systems designed for sustainable operational models. At the same time, regulatory scrutiny around device sterility, post-market surveillance, and clinical outcomes has intensified, prompting manufacturers to strengthen evidence packages. Taken together, these dynamics create a landscape in which clinical demand, hospital operational constraints, and regulatory imperatives converge to influence device design, distribution, and adoption.

How infection-control priorities, decentralized care pathways, and procurement focus on total cost of ownership are reshaping device design and commercialization strategies

The last several years have witnessed transformative shifts in how acute external ventricular drains are designed, supplied, and used within hospitals and specialty centers. Clinically, there is growing emphasis on minimizing infection and improving monitoring precision, which has driven adoption of closed-system technologies and integrated pressure-sensing capabilities. At the same time, healthcare delivery models are decentralizing certain neurosurgical procedures to ambulatory surgical centers and specialty clinics, altering demand patterns and influencing stocking strategies.

Moreover, procurement teams are increasingly focused on total cost of ownership, favoring disposable kits that reduce reprocessing burdens while also exploring reusable systems that can be optimized through robust sterilization protocols. Digital health integration and remote monitoring are beginning to appear in adjacent device ecosystems, and regulatory frameworks have tightened around traceability and adverse event reporting, prompting manufacturers to prioritize post-market data collection. These converging shifts are prompting incumbent suppliers and new entrants to reassess product roadmaps and commercial strategies to align with clinician preferences and institutional imperatives.

Anticipating the commercial and supply chain consequences of United States tariff realignment and the strategic choices manufacturers and health systems must weigh in 2025

United States tariff policy changes projected for 2025 introduce material considerations across the procurement and supply chain landscape for medical devices, including components and assembled acute external ventricular drains. Tariff adjustments affect the landed cost of imported materials and finished devices, which in turn can influence sourcing strategies, supplier negotiations, and the allocation of manufacturing capacity between domestic and offshore facilities. Procurement teams and manufacturers must therefore evaluate supplier contracts, hedging strategies, and potential price pass-through to end users while remaining mindful of hospital budget constraints.

In response, manufacturers may intensify efforts to localize production, qualify alternative suppliers, or redesign product kits to reduce reliance on tariff-impacted components. Hospitals and group purchasing organizations will likely increase scrutiny of contract terms and inventory practices, seeking greater transparency on cost drivers. Importantly, tariff-related cost pressures can also accelerate interest in disposable kits that simplify logistics, or conversely, renew focus on reusable systems where capital investment and local sterilization can mitigate import exposure. Navigating this environment requires coordinated scenario planning between commercial, regulatory, and supply chain teams to preserve margins while sustaining clinical availability.

A comprehensive segmentation-driven assessment revealing how clinical indications, care settings, product architectures, and distribution channels collectively influence device design and commercial pathways

Segmentation analysis reveals differentiated drivers and adoption pathways across clinical applications, end users, product typologies, technologies, drainage approaches, patient demographics, and distribution modalities. By application, device design and clinical workflows respond directly to needs in hydrocephalus management, intracranial pressure monitoring, subarachnoid hemorrhage treatment, and traumatic brain injury management, with each indication imposing unique requirements for monitoring fidelity, catheter durability, and infection control measures. Regarding end users, ambulatory surgical centers, hospitals, and specialty clinics vary in procedural volume, sterile processing capabilities, and purchasing authority, shaping the appeal of preassembled disposable kits versus systems intended for centralized reprocessing.

Product type segmentation highlights a tension between disposable kits and reusable systems. Disposable kits, which include advanced and standard configurations, appeal where single-use sterility and simplified procedural setup reduce infection risk and staff time, whereas reusable systems, available as multi-component and single-component formats, can be preferable where sterilization infrastructure and throughput support cost amortization. Technology segmentation separates closed systems from open systems; closed systems typically reduce contamination risk and support clinician preference in intensive care environments, while open systems retain relevance where simplicity and cost are paramount. Drainage type stratification into continuous versus intermittent approaches affects drainage hardware and monitoring cadence, and patient age segmentation into adult and pediatric populations drives design differences in catheter size, monitoring thresholds, and caregiver training. Finally, distribution channels encompass distributors, ecommerce, and hospital vendors; distributor categories include medical device and pharmaceutical distributors, ecommerce pathways traverse manufacturer websites and third-party platforms, and hospital vendors operate through direct hospital contracts and group purchasing organizations. Each distribution pathway requires tailored commercial engagement strategies, contractual constructs, and logistics planning to align product availability with clinical demand.

Regional dynamics and healthcare system nuances that determine adoption trajectories, regulatory obligations, and commercial strategies across global neurocritical care markets

Regional dynamics shape adoption patterns, regulatory expectations, and competitive intensity across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct opportunities and constraints. In the Americas, advanced neurocritical care capacity, concentration of tertiary neurological centers, and integrated hospital procurement frameworks favor adoption of feature-rich closed systems and advanced disposable kits, while private and public payor dynamics influence acquisition timing and contract structures. Transitional care models and emphasis on bundled payments prompt health systems to prioritize devices that demonstrate reductions in infection rates and length of stay.

Across Europe, Middle East & Africa, regulatory harmonization efforts and national reimbursement policies influence market entry and adoption. In Western Europe, stringent device regulations and high standards for clinical evidence drive manufacturers to invest in post-market studies and value demonstrations, whereas in parts of the Middle East and Africa, infrastructure variability creates pockets of demand for both cost-effective reusable systems and readily available disposable kits. In the Asia-Pacific region, rapidly expanding neurosurgical capacity, strong local manufacturing ecosystems, and evolving regulatory pathways create opportunities for both global suppliers and regional manufacturers. Price sensitivity in some markets coexists with rising demand for advanced solutions in urban tertiary centers, prompting manufacturers to offer differentiated product tiers and flexible commercial models tailored to regional needs.

Competitive landscape characterization highlighting how scale, clinical evidence, and service integration determine supplier differentiation and market positioning

Competitive dynamics in the acute external ventricular drain space are shaped by a mix of established medtech firms, specialized neurosurgical device companies, and agile niche innovators. Larger manufacturers leverage scale, global distribution networks, and broad clinical portfolios to secure hospital contracts and support complex value propositions that include training, post-market surveillance, and service agreements. Conversely, smaller specialized firms drive innovation around catheter design, closed-system technology, and integrated monitoring features, often partnering with clinical centers to validate performance and accelerate clinician acceptance.

Collaboration between original equipment manufacturers and contract manufacturers has deepened, enabling faster product iterations and cost optimization while also dispersing supply chain risk. Strategic differentiation increasingly relies on clinical evidence generation, infection mitigation features, and lifecycle service offerings rather than on price alone. In addition, channel strategies vary: some suppliers emphasize direct hospital contracts and group purchasing organization participation, while others exploit distributor networks and digital channels to expand reach. Ultimately, competitive positioning depends on the ability to align clinical claims with operational value and to demonstrate measurable improvements in patient outcomes and workflow efficiencies.

Actionable strategic priorities for manufacturers and health systems to fortify clinical outcomes, supply resilience, and differentiated commercial execution in neurocritical care

Industry leaders should prioritize actions that safeguard clinical performance while streamlining supply and commercial execution. First, invest in clinical studies and real-world evidence programs that quantify reductions in infection rates, ICU duration, and device-related complications to support procurement discussions and reimbursement alignment. Second, optimize product portfolios to cover both disposable advanced kits and reusable system options, allowing institutions to select solutions that align with their sterilization capabilities and cost-management objectives. Parallel to product optimization, strengthen supply chain resilience through dual sourcing, nearshoring critical components, and clear contingency planning for tariff-driven cost shifts.

Commercially, tailor engagement models by end user and region, offering flexible contract terms, training packages, and evidence-backed value propositions for ambulatory surgical centers, hospitals, and specialty clinics. Embrace digital channels and manufacturer-owned ecommerce to support rapid replenishment and to capture demand from decentralized care sites. Finally, collaborate with clinical leaders to co-develop protocols that simplify device setup and maintenance, thereby reducing variability in outcomes and enhancing the perceived value of premium device attributes.

A rigorous mixed-methods approach combining clinician insight, regulatory review, and scenario modeling to ensure comprehensive and validated analysis of device, clinical, and supply chain dynamics

The research methodology for this executive summary integrates qualitative and quantitative approaches to ensure a robust evidence base and balanced interpretation. Primary inputs include structured interviews with clinical leaders, procurement professionals, and engineering teams, complemented by observational analysis of procedural workflows in representative care settings. Secondary inputs draw on peer-reviewed clinical literature, regulatory documentation, device labeling, and manufacturer product specifications to substantiate technology capabilities and safety profiles.

Analytical techniques employed include comparative feature mapping across product typologies, scenario-based supply chain modeling to assess tariff impacts, and segmentation analysis to identify distinct demand clusters by application, end user, and distribution channel. Wherever possible, findings were cross-validated through clinician expert panels and technical reviews to ensure practical relevance. Limitations and data gaps were explicitly identified, with recommended follow-up research areas to deepen insight into long-term clinical outcomes and device lifecycle economics.

Synthesis of clinical, operational, and commercial imperatives that determines which strategic approaches will deliver sustained adoption and measurable patient-care improvements

In conclusion, acute external ventricular drain systems occupy a critical intersection of clinical necessity, operational imperatives, and commercial complexity. Clinical emphasis on infection control and monitoring precision is tilting preference toward closed systems and carefully configured disposable kits in many care settings, even as reusable systems retain strategic importance where sterilization infrastructure supports cost-effective reuse. Tariff changes and regional purchasing dynamics require proactive supply chain and commercial planning to sustain availability and preserve margin structures.

Manufacturers that pair strong clinical evidence with flexible product portfolios, resilient sourcing strategies, and targeted regional commercial approaches will be best positioned to meet evolving clinician and purchaser expectations. Health systems and procurement teams, by contrast, will benefit from clearer total cost of ownership analyses, tighter protocol alignment, and selective adoption of devices that demonstrably reduce complications and workflow burden. Continued collaboration between clinical stakeholders, manufacturers, and supply chain partners will be essential to translate innovation into measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of antimicrobial-coated catheters to reduce EVD-related infections and complications
  • 5.2. Integration of wireless intracranial pressure monitoring with EVD systems for real-time neurocritical care data
  • 5.3. Increasing demand for single-use disposable ventricular drains to minimize cross-contamination risks
  • 5.4. Development of minimally invasive catheter insertion techniques to shorten ICU stays in neurocritical patients
  • 5.5. Expansion of telemedicine-enabled EVD management platforms for remote monitoring and consultation
  • 5.6. Growing investments in smart external ventricular drain systems with pressure sensors and automated drainage control algorithms
  • 5.7. Regulatory approvals for novel silver-coated drains targeting multi-drug resistant pathogens in neurosurgical care
  • 5.8. Collaborations between device manufacturers and AI developers to optimize EVD placement and flow adjustment protocols in critical care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Acute External Ventricular Drain Market, by Application

  • 8.1. Hydrocephalus Management
  • 8.2. Intracranial Pressure Monitoring
  • 8.3. Subarachnoid Hemorrhage Treatment
  • 8.4. Traumatic Brain Injury Management

9. Acute External Ventricular Drain Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Acute External Ventricular Drain Market, by Product Type

  • 10.1. Disposable Kits
    • 10.1.1. Advanced Kits
    • 10.1.2. Standard Kits
  • 10.2. Reusable Systems
    • 10.2.1. Multi Component Systems
    • 10.2.2. Single Component Systems

11. Acute External Ventricular Drain Market, by Technology

  • 11.1. Closed Systems
  • 11.2. Open Systems

12. Acute External Ventricular Drain Market, by Drainage Type

  • 12.1. Continuous Drainage
  • 12.2. Intermittent Drainage

13. Acute External Ventricular Drain Market, by Patient Age Group

  • 13.1. Adult
  • 13.2. Pediatric

14. Acute External Ventricular Drain Market, by Distribution Channel

  • 14.1. Distributors
    • 14.1.1. Medical Device Distributors
    • 14.1.2. Pharmaceutical Distributors
  • 14.2. Ecommerce
    • 14.2.1. Manufacturer Websites
    • 14.2.2. Third Party Websites
  • 14.3. Hospital Vendors
    • 14.3.1. Direct Hospital Contracts
    • 14.3.2. Group Purchasing Organizations

15. Acute External Ventricular Drain Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Acute External Ventricular Drain Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Acute External Ventricular Drain Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Medtronic plc
    • 18.3.2. B. Braun Melsungen AG
    • 18.3.3. Integra LifeSciences Corporation
    • 18.3.4. Smiths Medical, Inc.
    • 18.3.5. Teleflex Incorporated
    • 18.3.6. Becton, Dickinson and Company
    • 18.3.7. Stryker Corporation
    • 18.3.8. ICU Medical, Inc.
    • 18.3.9. Baxter International Inc.
    • 18.3.10. Boston Scientific Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HYDROCEPHALUS MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBARACHNOID HEMORRHAGE TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TRAUMATIC BRAIN INJURY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADVANCED KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STANDARD KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MULTI COMPONENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SINGLE COMPONENT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY CONTINUOUS DRAINAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY INTERMITTENT DRAINAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MEDICAL DEVICE DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PHARMACEUTICAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY THIRD PARTY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DIRECT HOSPITAL CONTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY GROUP PURCHASING ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISPOSABLE KITS, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REUSABLE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DRAINAGE TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY DISTRIBUTORS, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY ECOMMERCE, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY HOSPITAL VENDORS, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE